Saotome K

ORCID: 0000-0002-5619-5148 · 2 papers in corpus

2025

High-Throughput Drug Screening of Clear Cell Ovarian Cancer Organoids Reveals Vulnerability to Proteasome Inhibitors and Dinaciclib and Identifies AGR2 as a Therapeutic Target.

Cancer research communications ·doi:10.1158/2767-9764.crc-25-0024

There are currently no effective treatments available for clear cell ovarian cancer (CCC). In this study, we aimed to identify effective drugs for CCC through high-throughput drug screening (HTDS) using ovarian cancer organoids and determin…

2020

Clinical implications of next-generation sequencing-based panel tests for malignant ovarian tumors.

Cancer medicine ·doi:10.1002/cam4.3383

Precision medicine based on cancer genomics is being applied in clinical practice. However, patients do not always derive benefits from genomic testing. Here, we performed targeted amplicon exome sequencing-based panel tests, including 160 …